Position in UTHR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,111,187
-$2,158,626 QoQ
Shares Held
5,742
-35.4% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#310
of 875 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Rafferty Asset Management, LLC holds $21,876,011 across 22 Drug Manufacturers - Specialty & Generic names. UTHR ranks #4 (14.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
48,590 | $3,491,677 | |
| 2 | ALKS |
Alkermes plc.
|
62,965 | $3,299,366 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
18,743 | $3,158,945 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
5,742 | $3,111,187 | |
| 5 | BCRX |
Biocryst Pharmaceuticals Inc
|
265,618 | $2,656,180 | |
| 6 | VTRS |
Viatris Inc
|
140,790 | $2,235,745 | |
| 7 | IRWD |
Ironwood Pharmaceuticals Inc
|
152,878 | $643,616 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
16,555 | $407,418 |
All Filings in UTHR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,111,187 | 5,742 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $5,269,813 | 8,887 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,199,281 | 12,723 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $8,837,785 | 21,082 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $10,217,591 | 35,558 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $11,086,005 | 35,962 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $13,437,558 | 38,084 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $18,260,082 | 50,956 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $20,846,867 | 65,443 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $8,667,335 | 37,730 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $8,168,033 | 37,146 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $8,927,285 | 39,524 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $8,016,315 | 36,314 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $6,671,992 | 29,791 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $8,001,205 | 28,772 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $6,502,086 | 31,054 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,087,647 | 17,347 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $5,545,563 | 30,910 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $6,042,461 | 27,964 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,735,106 | 14,818 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $2,613,106 | 14,565 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $3,492,095 | 20,877 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $1,020,332 | 6,722 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,954,855 | 19,355 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,000,791 | 8,271 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $487,805 | 5,144 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||